|
Home
Gamma Knife Performed Hydrocephalus Gamma Knife Explained Constant Dizziness and Acoustic Neuroma Don't Let Your Kids Use Mobile Phones Acoustic Neuroma Picture Symptoms and Anatomy of Acoustic Neuromas Signs of Acoustic Neuroma A Randomized Controlled Trial Tinnitus Pronunciation Symptoms of Acoustic Neuroma Symptoms Vestibular schwannoma with contralateral facial pain - case report Messageboard Treatment Feedback What is Acoustic Neuroma Dr. James Wong’s Radiation Treatment Site Map Top Web Sites
Surviving
Prostate Cancer Medical Sites -
Genitourinary ProstatitisAndBPH.org How we made this site
|
Spinal tumors in neurofibromatosis type 2. Is emerging knowledge of genotype predictive of natural hDow G, Biggs N, Evans G, Gillespie J, Ramsden R, King AJ Neurosurg Spine. 2005 May;2(5):574-9.. Department of Neurosurgery, Manchester Royal Infirmary, Manchester, United Kingdom. OBJECT: The authors conducted a study to examine the incidence, classification, and progression of spinal tumors in patients with neurofibromatosis Type 2 (NF2) treated at a single center, and to examine relationships with the known mutational subtypes of NF2. METHODS: They performed a retrospective review of clinical records, neuroimaging studies, and genetic data obtained in 61 patients with NF2. Forty-one (67%) of 61 patients harbored one or more spinal tumors. Thirty-four patients had undergone serial spinal magnetic resonance imaging during a mean follow-up period of 52 months (range 10-103 months; median 53 months). In 16 patients there were multiple extramedullary tumors smaller than 5 mm, which did not progress. Fourteen patients harbored at least one extramedullary tumor that was greater than 5 mm; of these, radiological progression was demonstrated or spinal tumor excision was performed during the follow-up period in eight cases (57%). Eleven patients harbored intramedullary cord tumors in addition to small and large extramedullary tumors, three (27%) of which exhibited radiological progression. In cases in which genotypes were known, protein-truncating mutations were significantly more likely to be associated with the presence of spinal tumors than in other types (p = 0.03, Fisher exact test). No associations between clinical behavior of spinal tumors and genotype, however, could be demonstrated. CONCLUSIONS: Spinal tumors in cases involving NF2 are heterogeneous in type, distribution, and behavior but larger-size tumors are more likely to progress significantly. Intramedullary tumors usually accompany multiple extramedullary tumors. In the authors' experience subtyping of the NF2 mutation has not yet influenced management. Protein-truncating mutations are associated with an increased prevalence of spinal tumors.< This abstract is being posted for educational purposes, as well as for comment and criticism, by the visitors to the Acoustic Neuroma Foundation website. This abstract is representative of a larger article that is indexed on Medline. Men's Health Web RingSurvivingProstateCancerWithoutSurgery.org VasectomyFoundation.org Prostatitis Foundation ( Prostatitis.org) Disclaimer: Information provided on this web site is for educatonal purposes only. It is not a substitute for, nor can it replace advice from your own physician. The information on this site is not to be used for diagnosing or treating any health concerns that you may have. You must see your own physician for diagnosis and treatment. Furthermore, the information on this site is never guaranteed to be 100% accurate or 100% up to date. All the side effects of mentioned treatments, drugs, surgeries, or therapies cannot always be listed or be known. Errors and omissions may occur in any essay. See a competent physician for your health care needs. http://www.acousticneuromafoundation.org™ Established December 11, 2002 |
|